These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 416176)

  • 1. Experimental respiratory syncytial virus infection of four species of primates.
    Belshe RB; Richardson LS; London WT; Sly DL; Lorfeld JH; Camargo E; Prevar DA; Chanock RM
    J Med Virol; 1977; 1(3):157-62. PubMed ID: 416176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness.
    Richardson LS; Belshe RB; London WT; Sly DL; Prevar DA; Camargo E; Chanock RM
    J Med Virol; 1978; 3(2):91-100. PubMed ID: 104004
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection.
    Belshe RB; Richardson LS; London WT; Sly DL; Camargo E; Prevar DA; Chanock RM
    J Med Virol; 1978; 3(2):101-10. PubMed ID: 104003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
    Karron RA; Wright PF; Crowe JE; Clements-Mann ML; Thompson J; Makhene M; Casey R; Murphy BR
    J Infect Dis; 1997 Dec; 176(6):1428-36. PubMed ID: 9395351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants.
    Prince GA; Suffin SC; Prevar DA; Camargo E; Sly DL; London WT; Chanock RM
    Infect Immun; 1979 Dec; 26(3):1009-13. PubMed ID: 118925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental respiratory syncytial virus pneumonia in cebus monkeys.
    Richardson LS; Belshe RB; Sly DL; London WT; Prevar DA; Camargo E; Chanock RM
    J Med Virol; 1978; 2(1):45-59. PubMed ID: 210254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys.
    Murphy BR; Sly DL; Hosier NT; London WT; Chanock RM
    Infect Immun; 1980 Jun; 28(3):688-91. PubMed ID: 6772565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus.
    Leschinskaya NP; Pokrovskaya EE; Kantorovitch EA; Grigorjeva SK; Shvartsman YaS
    Epidemiol Infect; 1988 Dec; 101(3):565-75. PubMed ID: 3215287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of rhesus monkeys and chimpanzees with Epstein-Barr virus.
    Levine PH; Leiseca SA; Hewetson JF; Traul KA; Andrese AP; Granlund DJ; Fabrizio P; Stevens DA
    Arch Virol; 1980; 66(4):341-51. PubMed ID: 6255902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The late detection of respiratory syncytial virus in cells of respiratory tract by immunofluorescence.
    Gardner PS; McQuillin J; McGuckin R
    J Hyg (Lond); 1970 Dec; 68(4):575-80. PubMed ID: 4923568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus neutralizing activity in nasopharyngeal secretions.
    Scott R; Gardner PS
    J Hyg (Lond); 1970 Dec; 68(4):581-8. PubMed ID: 5276332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
    Wright PF; Shinozaki T; Fleet W; Sell SH; Thompson J; Karzon DT
    J Pediatr; 1976 Jun; 88(6):931-6. PubMed ID: 178852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.
    Williams JV; Tollefson SJ; Johnson JE; Crowe JE
    J Virol; 2005 Sep; 79(17):10944-51. PubMed ID: 16103146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees.
    Skiadopoulos MH; Surman SR; Riggs JM; Elkins WR; St Claire M; Nishio M; Garcin D; Kolakofsky D; Collins PL; Murphy BR
    Virology; 2002 May; 297(1):153-60. PubMed ID: 12083845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A primate model of respiratory syncytial virus infection.
    Babu PG; Selvan A; Christuraj S; David J; John TJ; Simoes EA
    Indian J Exp Biol; 1998 Aug; 36(8):758-62. PubMed ID: 9838875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically useful method for the isolation of respiratory syncytial virus.
    Hall CB; Douglas RG
    J Infect Dis; 1975 Jan; 131(1):1-5. PubMed ID: 162921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection.
    Durbin AP; Elkins WR; Murphy BR
    Vaccine; 2000 May; 18(22):2462-9. PubMed ID: 10738104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.